关注
Yannick Le Meur
Yannick Le Meur
EA2216, INSERM ERI29
在 chu-brest.fr 的电子邮件经过验证
标题
引用次数
引用次数
年份
Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference
P Wallemacq, VW Armstrong, M Brunet, V Haufroid, DW Holt, A Johnston, ...
Therapeutic drug monitoring 31 (2), 139-152, 2009
5442009
Type of PKD1 mutation influences renal outcome in ADPKD
E Cornec-Le Gall, MP Audrézet, JM Chen, M Hourmant, MP Morin, ...
Journal of the American Society of Nephrology 24 (6), 1006-1013, 2013
5362013
Individualized mycophenolate mofetil dosing based on drug exposure significantly improves patient outcomes after renal transplantation
Y Le Meur, M Büchler, A Thierry, S Caillard, F Villemain, S Lavaud, ...
American Journal of Transplantation 7 (11), 2496-2503, 2007
4872007
Mutations in GANAB, encoding the glucosidase IIα subunit, cause autosomal-dominant polycystic kidney and liver disease
B Porath, VG Gainullin, E Cornec-Le Gall, EK Dillinger, CM Heyer, ...
The American Journal of Human Genetics 98 (6), 1193-1207, 2016
472*2016
Optimization of initial tacrolimus dose using pharmacogenetic testing
E Thervet, MA Loriot, S Barbier, M Buchler, M Ficheux, G Choukroun, ...
Clinical Pharmacology & Therapeutics 87 (6), 721-726, 2010
4112010
Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation
DRJ Kuypers, Y Le Meur, M Cantarovich, MJ Tredger, SE Tett, D Cattaneo, ...
Clinical journal of the American Society of Nephrology 5 (2), 341-358, 2010
3672010
The PROPKD score: a new algorithm to predict renal survival in autosomal dominant polycystic kidney disease
E Cornec-Le Gall, MP Audrézet, A Rousseau, M Hourmant, ...
Journal of the American Society of Nephrology 27 (3), 942-951, 2016
3632016
Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism
N Picard, D Ratanasavanh, A Prémaud, Y Le Meur, P Marquet
Drug metabolism and disposition 33 (1), 139-146, 2005
3342005
Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney …
RT Gansevoort, M Arici, T Benzing, H Birn, G Capasso, A Covic, ...
Nephrology Dialysis Transplantation 31 (3), 337-348, 2016
3222016
Efficacy on renal function of early conversion from cyclosporine to sirolimus 3 months after renal transplantation: concept study
Y Lebranchu, A Thierry, O Toupance, PF Westeel, I Etienne, E Thervet, ...
American Journal of Transplantation 9 (5), 1115-1123, 2009
3042009
Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy
Y Lebranchu, F Bridoux, M Büchler, Y Le Meur, I Etienne, O Toupance, ...
American Journal of Transplantation 2 (1), 48-56, 2002
2942002
Monoallelic mutations to DNAJB11 cause atypical autosomal-dominant polycystic kidney disease
E Cornec-Le Gall, RJ Olson, W Besse, CM Heyer, VG Gainullin, JM Smith, ...
The American Journal of Human Genetics 102 (5), 832-844, 2018
2842018
An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants
S Caillard, D Anglicheau, M Matignon, A Durrbach, C Greze, L Frimat, ...
Kidney international 98 (6), 1549-1558, 2020
2662020
CYP3A5 and MDR1 Genetic Polymorphisms and Cyclosporine Pharmacokinetics After Renal Transplantation
D Anglicheau, E Thervet, I Etienne, B Hurault De Ligny, Y Le Meur, ...
Clinical Pharmacology & Therapeutics 75 (5), 422-433, 2004
2532004
Is COVID‐19 infection more severe in kidney transplant recipients?
S Caillard, N Chavarot, H Francois, M Matignon, C Greze, N Kamar, ...
American Journal of Transplantation 21 (3), 1295-1303, 2021
2422021
Sirolimus versus cyclosporine in kidney recipients receiving Thymoglobulin®, mycophenolate mofetil and a 6‐month course of steroids
M Büchler, S Caillard, S Barbier, E Thervet, O Toupance, H Mazouz, ...
American Journal of Transplantation 7 (11), 2522-2531, 2007
2002007
The role of organic anion–transporting polypeptides and their common genetic variants in mycophenolic acid pharmacokinetics
N Picard, SW Yee, JB Woillard, Y Lebranchu, Y Le Meur, KM Giacomini, ...
Clinical Pharmacology & Therapeutics 87 (1), 100-108, 2010
1952010
Tacrolimus population pharmacokinetic-pharmacogenetic analysis and Bayesian estimation in renal transplant recipients
K Benkali, A Prémaud, N Picard, JP Rérolle, O Toupance, G Hoizey, ...
Clinical pharmacokinetics 48, 805-816, 2009
1622009
B-Cells induce regulatory T cells through TGF-β/IDO production in A CTLA-4 dependent manner
A Nouel, P Pochard, Q Simon, I Segalen, Y Le Meur, JO Pers, S Hillion
Journal of autoimmunity 59, 53-60, 2015
1532015
Correction of postkidney transplant anemia reduces progression of allograft nephropathy
G Choukroun, N Kamar, B Dussol, I Etienne, E Cassuto-Viguier, ...
Journal of the American Society of Nephrology 23 (2), 360-368, 2012
1532012
系统目前无法执行此操作,请稍后再试。
文章 1–20